Target intelligence / Profile preview

MicroRNA 6823 (MIR6823)

Target
MIR6823
Molecular classification
microRNA, non-coding RNA
01

Overview

MicroRNA 6823 (MIR6823) is a predicted human microRNA gene encoding a short, non-coding RNA molecule that is part of the microRNA (miRNA) family[1]. Like other miRNAs, MIR6823 is likely involved in the post-transcriptional regulation of gene expression by binding predominantly to the 3′ untranslated regions (UTRs) of target mRNAs, leading to either translational repression or degradation of the mRNA[1][5][3]. This process is critical for fine-tuning gene expression in multicellular organisms. However, there is no evidence in the scientific literature or curated gene databases as of this date for any specific regulatory targets, disease association, biomarker utility, or suitability as a therapeutic target for MIR6823 in humans. The available data supports its classification as a generic member of the human miRNA family, but not as a receptor, enzyme, transporter, or established therapeutic target[1].

Other names
hsa-mir-6823hsa-mir-6823 (redundant, likely a repetition in source)microRNA mir-6823MIR6823[1]
02

Mechanism of action

Not applicable/no known drug mechanisms (as it is not an established drug target)[1][5]

03

Biological functions

Post-transcriptional regulation of gene expression (general to all microRNAs)[1][5][3]Likely involved in mRNA stability and translation control (as with other miRNAs)[1][5][3]Other (as the specific functions of MIR6823 are not reported in available data)
04

Disease associations

Unknown/Other (No specific disease roles for MIR6823 are reported in the literature or gene databases as of this date)[1]
05

Safety considerations

None reported
06

Interacting drugs

None known (No known drugs specifically target MIR6823)[1][5]
07

Biomarkers

None known for MIR6823 (no validated patient selection or outcome biomarkers listed for this specific microRNA)[1]

Beyond the preview

Go deeper on MicroRNA 6823 (MIR6823).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 6823 (MIR6823).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call